Telomir Pharmaceuticals, Inc. /
TELI Pharmaceuticals, Inc.
Telomir completes purchase of TELI Pharmaceuticals




Source for the buyer and target: Telomir Pharmaceuticals, Inc.
For the buyer and target.
“On April 22, 2026, Telomir Pharmaceuticals, Inc. (the “Company”) completed its acquisition of TELI Pharmaceuticals, Inc. (“TELI”) pursuant to the previously announced merger agreement (the “Transaction”).”
Published 24 Apr 2026
Open the sourceWhat happened
Telomir Pharmaceuticals, Inc. has completed its acquisition of TELI Pharmaceuticals, Inc. under a previously announced merger agreement. At closing, TELI's former shareholders received 34,389,710 restricted shares of Telomir common stock, and the transaction consolidates worldwide rights to the Telomir-1 platform under a single corporate structure. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Telomir completes purchase of TELI Pharmaceuticals
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly